(+)-Myrrhanol C made


Spanish chemists have completed the stereospecific total synthesis of (+)-myrrhanol C.

(+)-Myrrhanol C is a natural triterpene isolated from mastic gum (the resin of Pistacia lentiscus), a substance well known for its medicinal properties as well as use in various cuisines. The compound itself was used to embalm corpses in ancient Egypt. More recently, it has been recognised as a promising anti-prostate cancer lead. However, before a molecule can be used to develop drugs, a successful synthesis must be developed.

Pistacia lentiscus

Mastic gum (from Pistacia lentiscus, pictured) has been used for many applications, from treating snakebites to tooth whiteners. © Science Photo Library

Alejandro Barrero and his group at the University of Granada have done just that. Their synthesis starts with (–)-sclareol, a bicyclic diterpene alcohol isolated from clary sage (Salvia sclarea). It then proceeds through a key C–H oxidation step, which is achieved with cytochrome P450 enzyme catalysis by incubating a reaction intermediate with the fungus Mucor plumbeus.

By cultivating clary sage, Barrero can sustainably produce (–)-sclareol, meaning (+)-myrrhanol C can be made on a large scale that is also environmentally friendly.

However, the use of natural products and processes in the synthesis also gives another important benefit to the synthetic strategy. ‘Apart from using a natural chiral synthon as starting material, the only process generating a new chiral centre is the microbial hydroxylation,’ explains Barrero. This means the researchers could carefully control the stereochemistry of the synthetic product, which could be very important for clinical applications. ‘The selectivity [for the (+) isomer] of our synthesis is total,’ he concludes.

Bob Hill, a natural products expert at the University of Glasgow, welcomes the synthesis of (+)-myrrhanol C even though he is not enthused by the chemistry. ‘They seem to have produced a reasonably good synthesis (using established methodology) to a potentially useful compound,’ he says.

Barrero says that the next step is to investigate synthetic analogues and their antitumour activity with a view to drug discovery.


Related Content

The sultan of synthesis

11 April 2014 Feature

news image

Phil Baran is spurring organic chemists to rethink how they make complex compounds, as Mark Peplow discovers

Chemistry's toughest total synthesis challenge put on hold by lack of funds

15 January 2015 Research

news image

'Seemingly impossible' synthesis of highly potent poison maitotoxin nears completion after eight years

Most Read

Complex amines made easy (and cheap)

22 May 2015 Research

news image

Iron-catalysed cross-coupling brings together nitroarenes and olefins in a single step in boon for drug makers

Opiate-producing yeast raises spectre of 'home-brewed heroin'

18 May 2015 News and Analysis

news image

Warnings that completion of final steps in opiate biosynthesis could be a double-edged sword

Most Commented

The nuclear danger of iodine

20 May 2015 Comments

news image

It may not be an element you think of as problematic. But, as Mark Foreman explains, iodine causes very complicated problems ...

Opiate-producing yeast raises spectre of 'home-brewed heroin'

18 May 2015 News and Analysis

news image

Warnings that completion of final steps in opiate biosynthesis could be a double-edged sword